{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:39Z","timestamp":1793140719626,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Parkinson's disease is neurodegenerative disorder with an initial robust response to levodopa. As the disease progresses, patients frequently develop dyskinesia and motor fluctuations, which are sometimes resistant to pharmacological therapy. In recent years, abnormalities in gut microbiota have been identified in these patients with a possible role in motor manifestations. Dysbiosis may reduce levodopa absorption leading to delayed \u201cOn\u201d or \u201cno-On\u201d states. Among 84 consecutive patients with PD, we selected 14 with levodopa-induced dyskinesia and motor fluctuations with a Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part IV \u2265 8 points following a trial of pharmacological adjustment 2\u20133 months prior to study enrollment or adjustments in deep brain stimulation therapy. Patients received treatment with sodium phosphate enema followed by oral rifaximin and polyethylene glycol for 7 and 10 days, respectively. Evaluations between 14 to 21 days after starting treatment showed improvement in MDS-UPDRS-IV (<jats:italic>P<\/jats:italic> = 0.001), including duration (<jats:italic>P<\/jats:italic> = 0.001) and severity of dyskinesia (<jats:italic>P<\/jats:italic> = 0.003); duration of medication \u201cOff\u201d-state (<jats:italic>P<\/jats:italic> = 0.004); functional impact of motor fluctuations (<jats:italic>P<\/jats:italic> = 0.047) and complexity of motor fluctuations (<jats:italic>P<\/jats:italic> = 0.031); no statistical improvement was observed in \u201cOff\u201d dystonia (<jats:italic>P<\/jats:italic> = 0.109) and total motor scores (<jats:italic>P<\/jats:italic> = 0.430). Marked to moderate improvement in dyskinesia was observed in 57% of cases with blinded evaluation of videos. About 80% of patients perceived moderate to robust improvement at follow-up. A therapeutic strategy aimed at decontamination of intestines showed benefit in motor fluctuations and dyskinesia. Further studies should confirm and clarify the mechanism of improvement observed in these patients.<\/jats:p>","DOI":"10.3389\/fneur.2021.729961","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T05:34:37Z","timestamp":1631252077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Alonso-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"11","author":"Jankovic","year":"2005","journal-title":"Mov Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/1673-5374.290896","article-title":"Gut microbiota: a potential therapeutic target for Parkinson's disease","volume":"16","author":"Baizabal-Carvallo","year":"2021","journal-title":"Neural Regen Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.02.030","article-title":"The link between gut dysbiosis and neuroinflammation in Parkinson's disease","volume":"432","author":"Baizabal-Carvallo","year":"2020","journal-title":"Neuroscience."},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","article-title":"Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease","volume":"123","author":"Niu","year":"2016","journal-title":"J Neural Transm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1136\/gutjnl-2014-307240","article-title":"Effects of bowel cleansing on the intestinal microbiota","volume":"64","author":"Jalanka","year":"2015","journal-title":"Gut."},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s002470050583","article-title":"Evaluation of a method of assessing faecal loading onn plain abdominal radiographs in children","volume":"29","author":"Leech","year":"1999","journal-title":"Pediatr Radiol."},{"key":"B11","first-page":"28","article-title":"The clinical global impressions scale. Applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fneur.2019.00621","article-title":"Severe constipation in Parkinson's disease and in parkinsonisms: prevalence and affecting factors","volume":"10","author":"Frazzitta","year":"2019","journal-title":"Front Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0032-1301760","article-title":"Fecal impaction: a cause for concern?","volume":"25","author":"Obokhare","year":"2012","journal-title":"Clin Colon Rectal Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MEG.0000000000000581","article-title":"Persisting changes of intestinal microbiota after bowel lavage and colonoscopy","volume":"28","author":"Drago","year":"2016","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1038\/s41598-019-40182-9","article-title":"Effects of bowel preparation on the human gut microbiome and metabolome","volume":"9","author":"Nagata","year":"2019","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e32545","DOI":"10.1371\/journal.pone.0032545","article-title":"Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon","volume":"7","author":"Harrell","year":"2012","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12941-014-0049-x","article-title":"Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome","volume":"13","author":"Boltin","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00078","DOI":"10.14309\/ctg.0000000000000078","article-title":"Small intestinal bacterial overgrowth: clinical features and therapeutic management","volume":"10","author":"Rao","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/ejn.13482","article-title":"l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?","volume":"45","author":"Carta","year":"2017","journal-title":"Eur J Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuroscience.2008.07.016","article-title":"Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta","volume":"156","author":"Barnum","year":"2008","journal-title":"Neuroscience."},{"key":"B22","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism","volume":"364","author":"Rekdal","year":"2019","journal-title":"Science."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","article-title":"Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson's disease","volume":"9","author":"Hegelmaier","year":"2020","journal-title":"Cells."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e62815","DOI":"10.1371\/journal.pone.0062815","article-title":"Impact of colonoscopy bowel preparation on intestinal microbiota","volume":"8","author":"O'Brien","year":"2013","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.729961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T05:34:42Z","timestamp":1631252082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.729961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":26,"alternative-id":["10.3389\/fneur.2021.729961"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.729961","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"article-number":"729961"}}